Market revenue in 2023 | USD 271.2 million |
Market revenue in 2030 | USD 406.3 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Switzerland in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Federal Statistical Office, the number of children born in Switzerland through the utilization of ART, specifically IVF, increased by 13% in 2021 compared to the previous year. The data indicates that approximately 2,500 children were born as a result of IVF treatments during that period.
In addition, in around 35% of cases, infertility was attributed to the man, while in approximately 27% of cases, the woman was identified as the cause of infertility. In the remaining instances, either both partners had infertility issues or the cause of infertility remained unclear.
Furthermore, Switzerland attracts some medical tourists seeking IVF treatments due to its reputation for high-quality healthcare services. Factors such as the expertise of Swiss fertility specialists and the country's scenic locations contribute to its appeal.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account